Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study

Lymphovascular invasion (LVSI) is defined as the presence of tumor cells within a definite endothelial-lined space (lymphatics or blood vessels) in the organ surrounding invasive carcinoma. The presence of LVI is associated with an increased risk of lymph nodes and distant metastases. Lymphovascular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024, Vol.25 (6)
Hauptverfasser: Sulaiman, Raed, Dale, Adam, Lin, Xiaoqian, Aske, Jennifer C, Gaster, Kris, Starks, David, Espaillat, Luis Rojas, De, Pradip, Dey, Nandini
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page
container_title International journal of molecular sciences
container_volume 25
creator Sulaiman, Raed
Dale, Adam
Lin, Xiaoqian
Aske, Jennifer C
Gaster, Kris
Starks, David
Espaillat, Luis Rojas
De, Pradip
Dey, Nandini
description Lymphovascular invasion (LVSI) is defined as the presence of tumor cells within a definite endothelial-lined space (lymphatics or blood vessels) in the organ surrounding invasive carcinoma. The presence of LVI is associated with an increased risk of lymph nodes and distant metastases. Lymphovascular invasion is described as cancer within blood or lymph vessels and is an independent risk factor for metastasis, recurrence, and mortality. This study aims to present the marker-based immunohistological characterization of cells around LVSI in a high-grade adenocarcinoma of the endometrium to build a cellular atlas of cells of LVSI. A cellular characterization of the cells around lymphovascular space invasion in a 67-year-old female patient with invasive high-grade serous endometrial adenocarcinomas is presented. Resected tumor tissue from a consented patient with invasive high-grade serous endometrial adenocarcinoma was obtained within an hour of surgery. The expressions of the epithelial markers (CK8, 18, and EpCAM), LCA (leukocyte common antigen) marker (CD45), proliferation marker (Ki67), apoptosis markers (cleaved PARP and cleaved caspase3), immune cell markers (CD3, CD4, CD8, CD56, CD68, CD163, FoxP3, PD-1, PD-L1), pro-inflammatory marker (IL-12-RB2), and fibroblast/mesenchyme markers (S100A7, SMA, and TE-7) of the resected tissue on the IHC stains were evaluated and scored by a pathologist. Acknowledging the deterministic role of LVSI in a high-grade adenocarcinoma of the endometrium, our study presents the first marker-based immunohistological atlas of the tumor and TME compartments in the context of epithelial cell markers, proliferation markers, apoptosis markers, macrophage markers, and fibroblast markers. Our study demonstrates that an aggressive disease like a high-grade adenocarcinoma of the endometrium inflicts the pro-metastatic event of LVSI by involving the immune landscape of both tumor and TME. This study demonstrates, for the first time, that the tumor cells within LVSI are positive for IL-12R-B2 and S100A4.
doi_str_mv 10.3390/ijms25063441
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3014007834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3014007834</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_30140078343</originalsourceid><addsrcrecordid>eNqVjk1qwzAQhUWh0PRn1wPMMl24lS0nabozJk0C6cqh2zDIk0ZBGrmSFchBet-akgt09T4eH48nxGMun5WayxdzdLGYyKkqy_xKjPKyKDIpp7MbcRvjUcpCFZP5SPxUvcUIfg_b5HwA5PZCH0YHT3wywbMj7qEma__Mzdl1B3_CqJPFAE2HmmDNQ2E8w3jz2ayfwDCszNchWwZsCRoKPkVYcOsd9cGghaol9hqDNuwdvkEFNcbB7FN7vhfXe7SRHi55J8bvi229yrrgvxPFfudM1MMfZBp2d0rmpZSzV1Wqf6i_XjhfWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>3014007834</pqid></control><display><type>report</type><title>Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Sulaiman, Raed ; Dale, Adam ; Lin, Xiaoqian ; Aske, Jennifer C ; Gaster, Kris ; Starks, David ; Espaillat, Luis Rojas ; De, Pradip ; Dey, Nandini</creator><creatorcontrib>Sulaiman, Raed ; Dale, Adam ; Lin, Xiaoqian ; Aske, Jennifer C ; Gaster, Kris ; Starks, David ; Espaillat, Luis Rojas ; De, Pradip ; Dey, Nandini</creatorcontrib><description>Lymphovascular invasion (LVSI) is defined as the presence of tumor cells within a definite endothelial-lined space (lymphatics or blood vessels) in the organ surrounding invasive carcinoma. The presence of LVI is associated with an increased risk of lymph nodes and distant metastases. Lymphovascular invasion is described as cancer within blood or lymph vessels and is an independent risk factor for metastasis, recurrence, and mortality. This study aims to present the marker-based immunohistological characterization of cells around LVSI in a high-grade adenocarcinoma of the endometrium to build a cellular atlas of cells of LVSI. A cellular characterization of the cells around lymphovascular space invasion in a 67-year-old female patient with invasive high-grade serous endometrial adenocarcinomas is presented. Resected tumor tissue from a consented patient with invasive high-grade serous endometrial adenocarcinoma was obtained within an hour of surgery. The expressions of the epithelial markers (CK8, 18, and EpCAM), LCA (leukocyte common antigen) marker (CD45), proliferation marker (Ki67), apoptosis markers (cleaved PARP and cleaved caspase3), immune cell markers (CD3, CD4, CD8, CD56, CD68, CD163, FoxP3, PD-1, PD-L1), pro-inflammatory marker (IL-12-RB2), and fibroblast/mesenchyme markers (S100A7, SMA, and TE-7) of the resected tissue on the IHC stains were evaluated and scored by a pathologist. Acknowledging the deterministic role of LVSI in a high-grade adenocarcinoma of the endometrium, our study presents the first marker-based immunohistological atlas of the tumor and TME compartments in the context of epithelial cell markers, proliferation markers, apoptosis markers, macrophage markers, and fibroblast markers. Our study demonstrates that an aggressive disease like a high-grade adenocarcinoma of the endometrium inflicts the pro-metastatic event of LVSI by involving the immune landscape of both tumor and TME. This study demonstrates, for the first time, that the tumor cells within LVSI are positive for IL-12R-B2 and S100A4.</description><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25063441</identifier><language>eng</language><ispartof>International journal of molecular sciences, 2024, Vol.25 (6)</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27902</link.rule.ids></links><search><creatorcontrib>Sulaiman, Raed</creatorcontrib><creatorcontrib>Dale, Adam</creatorcontrib><creatorcontrib>Lin, Xiaoqian</creatorcontrib><creatorcontrib>Aske, Jennifer C</creatorcontrib><creatorcontrib>Gaster, Kris</creatorcontrib><creatorcontrib>Starks, David</creatorcontrib><creatorcontrib>Espaillat, Luis Rojas</creatorcontrib><creatorcontrib>De, Pradip</creatorcontrib><creatorcontrib>Dey, Nandini</creatorcontrib><title>Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study</title><title>International journal of molecular sciences</title><description>Lymphovascular invasion (LVSI) is defined as the presence of tumor cells within a definite endothelial-lined space (lymphatics or blood vessels) in the organ surrounding invasive carcinoma. The presence of LVI is associated with an increased risk of lymph nodes and distant metastases. Lymphovascular invasion is described as cancer within blood or lymph vessels and is an independent risk factor for metastasis, recurrence, and mortality. This study aims to present the marker-based immunohistological characterization of cells around LVSI in a high-grade adenocarcinoma of the endometrium to build a cellular atlas of cells of LVSI. A cellular characterization of the cells around lymphovascular space invasion in a 67-year-old female patient with invasive high-grade serous endometrial adenocarcinomas is presented. Resected tumor tissue from a consented patient with invasive high-grade serous endometrial adenocarcinoma was obtained within an hour of surgery. The expressions of the epithelial markers (CK8, 18, and EpCAM), LCA (leukocyte common antigen) marker (CD45), proliferation marker (Ki67), apoptosis markers (cleaved PARP and cleaved caspase3), immune cell markers (CD3, CD4, CD8, CD56, CD68, CD163, FoxP3, PD-1, PD-L1), pro-inflammatory marker (IL-12-RB2), and fibroblast/mesenchyme markers (S100A7, SMA, and TE-7) of the resected tissue on the IHC stains were evaluated and scored by a pathologist. Acknowledging the deterministic role of LVSI in a high-grade adenocarcinoma of the endometrium, our study presents the first marker-based immunohistological atlas of the tumor and TME compartments in the context of epithelial cell markers, proliferation markers, apoptosis markers, macrophage markers, and fibroblast markers. Our study demonstrates that an aggressive disease like a high-grade adenocarcinoma of the endometrium inflicts the pro-metastatic event of LVSI by involving the immune landscape of both tumor and TME. This study demonstrates, for the first time, that the tumor cells within LVSI are positive for IL-12R-B2 and S100A4.</description><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><recordid>eNqVjk1qwzAQhUWh0PRn1wPMMl24lS0nabozJk0C6cqh2zDIk0ZBGrmSFchBet-akgt09T4eH48nxGMun5WayxdzdLGYyKkqy_xKjPKyKDIpp7MbcRvjUcpCFZP5SPxUvcUIfg_b5HwA5PZCH0YHT3wywbMj7qEma__Mzdl1B3_CqJPFAE2HmmDNQ2E8w3jz2ayfwDCszNchWwZsCRoKPkVYcOsd9cGghaol9hqDNuwdvkEFNcbB7FN7vhfXe7SRHi55J8bvi229yrrgvxPFfudM1MMfZBp2d0rmpZSzV1Wqf6i_XjhfWA</recordid><startdate>20240319</startdate><enddate>20240319</enddate><creator>Sulaiman, Raed</creator><creator>Dale, Adam</creator><creator>Lin, Xiaoqian</creator><creator>Aske, Jennifer C</creator><creator>Gaster, Kris</creator><creator>Starks, David</creator><creator>Espaillat, Luis Rojas</creator><creator>De, Pradip</creator><creator>Dey, Nandini</creator><scope>7X8</scope></search><sort><creationdate>20240319</creationdate><title>Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study</title><author>Sulaiman, Raed ; Dale, Adam ; Lin, Xiaoqian ; Aske, Jennifer C ; Gaster, Kris ; Starks, David ; Espaillat, Luis Rojas ; De, Pradip ; Dey, Nandini</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_30140078343</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sulaiman, Raed</creatorcontrib><creatorcontrib>Dale, Adam</creatorcontrib><creatorcontrib>Lin, Xiaoqian</creatorcontrib><creatorcontrib>Aske, Jennifer C</creatorcontrib><creatorcontrib>Gaster, Kris</creatorcontrib><creatorcontrib>Starks, David</creatorcontrib><creatorcontrib>Espaillat, Luis Rojas</creatorcontrib><creatorcontrib>De, Pradip</creatorcontrib><creatorcontrib>Dey, Nandini</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sulaiman, Raed</au><au>Dale, Adam</au><au>Lin, Xiaoqian</au><au>Aske, Jennifer C</au><au>Gaster, Kris</au><au>Starks, David</au><au>Espaillat, Luis Rojas</au><au>De, Pradip</au><au>Dey, Nandini</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study</atitle><jtitle>International journal of molecular sciences</jtitle><date>2024-03-19</date><risdate>2024</risdate><volume>25</volume><issue>6</issue><eissn>1422-0067</eissn><abstract>Lymphovascular invasion (LVSI) is defined as the presence of tumor cells within a definite endothelial-lined space (lymphatics or blood vessels) in the organ surrounding invasive carcinoma. The presence of LVI is associated with an increased risk of lymph nodes and distant metastases. Lymphovascular invasion is described as cancer within blood or lymph vessels and is an independent risk factor for metastasis, recurrence, and mortality. This study aims to present the marker-based immunohistological characterization of cells around LVSI in a high-grade adenocarcinoma of the endometrium to build a cellular atlas of cells of LVSI. A cellular characterization of the cells around lymphovascular space invasion in a 67-year-old female patient with invasive high-grade serous endometrial adenocarcinomas is presented. Resected tumor tissue from a consented patient with invasive high-grade serous endometrial adenocarcinoma was obtained within an hour of surgery. The expressions of the epithelial markers (CK8, 18, and EpCAM), LCA (leukocyte common antigen) marker (CD45), proliferation marker (Ki67), apoptosis markers (cleaved PARP and cleaved caspase3), immune cell markers (CD3, CD4, CD8, CD56, CD68, CD163, FoxP3, PD-1, PD-L1), pro-inflammatory marker (IL-12-RB2), and fibroblast/mesenchyme markers (S100A7, SMA, and TE-7) of the resected tissue on the IHC stains were evaluated and scored by a pathologist. Acknowledging the deterministic role of LVSI in a high-grade adenocarcinoma of the endometrium, our study presents the first marker-based immunohistological atlas of the tumor and TME compartments in the context of epithelial cell markers, proliferation markers, apoptosis markers, macrophage markers, and fibroblast markers. Our study demonstrates that an aggressive disease like a high-grade adenocarcinoma of the endometrium inflicts the pro-metastatic event of LVSI by involving the immune landscape of both tumor and TME. This study demonstrates, for the first time, that the tumor cells within LVSI are positive for IL-12R-B2 and S100A4.</abstract><doi>10.3390/ijms25063441</doi></addata></record>
fulltext fulltext
identifier EISSN: 1422-0067
ispartof International journal of molecular sciences, 2024, Vol.25 (6)
issn 1422-0067
language eng
recordid cdi_proquest_miscellaneous_3014007834
source MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central; EZB Electronic Journals Library
title Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A10%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Atlas%20of%20Tumor%20and%20Tumor%20Microenvironment%20Cells%20of%20Lymphovascular%20Space%20Invasion%20(LVSI)%20in%20High-Grade%20Serous%20Endometrial%20Adenocarcinoma:%20A%20Case%20Study&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Sulaiman,%20Raed&rft.date=2024-03-19&rft.volume=25&rft.issue=6&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25063441&rft_dat=%3Cproquest%3E3014007834%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3014007834&rft_id=info:pmid/&rfr_iscdi=true